Abstract

Previously, we found that orally administered acetic acid decreased lipogenesis in the liver and suppressed lipid accumulation in adipose tissue of Otsuka Long-Evans Tokushima Fatty rats, which exhibit hyperglycemic obesity with hyperinsulinemia and insulin resistance. Administered acetic acid led to increased phosphorylation of AMP-activated protein kinase (AMPK) in both liver and skeletal muscle cells, and increased transcripts of myoglobin and glucose transporter 4 (GLUT4) genes in skeletal muscle of the rats. It was suggested that acetic acid improved the lipid metabolism in skeletal muscles. In this study, we examined the activation of AMPK and the stimulation of GLUT4 and myoglobin expression by acetic acid in skeletal muscle cells to clarify the physiological function of acetic acid in skeletal muscle cells. Acetic acid added to culture medium was taken up rapidly by L6 cells, and AMPK was phosphorylated upon treatment with acetic acid. We observed increased gene and protein expression of GLUT4 and myoglobin. Uptake of glucose and fatty acids by L6 cells were increased, while triglyceride accumulation was lower in treated cells compared to untreated cells. Furthermore, treated cells also showed increased gene and protein expression of myocyte enhancer factor 2A (MEF2A), which is a well-known transcription factor involved in the expression of myoglobin and GLUT4 genes. These results indicate that acetic acid enhances glucose uptake and fatty acid metabolism through the activation of AMPK, and increases expression of GLUT4 and myoglobin.

Highlights

  • Obesity and type 2 diabetes are increasing throughout the world

  • The uptake of glucose and fatty acid by cells were increased, while triglyceride accumulation was decreased upon treatment with acetic acid. These results indicate that treatment with acetic acid increases the expression of myoglobin and glucose transporter 4 (GLUT4) via the activation of AMPK and myocyte enhancer factor 2A (MEF2A), enhancing fatty acid metabolism and glucose uptake

  • Antibodies against AMPKα, phosphorylated AMPKα, ACC, phosphorylated ACC, and GLUT4 were purchased from Cell Signaling (MA, USA), antibodies against myoglobin, MEF2A, PGC-1α and Sp1 were from Santa Cruz Biotechnology (CA, USA), and α-tubulin antibody was from Wako Pure Chemical Industries Ltd. (Osaka, Japan)

Read more

Summary

Introduction

Obesity and type 2 diabetes are increasing throughout the world. The International Diabetes Federation Diabetes Atlas reported that there were 382 million people living with diabetes in the world in 2013. This number is expected to rise to 592 million by 2035 [1]. Obesity leads to excess lipid accumulation in adipose tissue, skeletal muscle, and liver. Lipid accumulation in muscle causes a decline of insulin sensitivity [2,3,4,5].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call